Shohei Koide, PhDProfessor of Biologics Design, Department of Biochemistry and Molecular Pharmacology at NYU Grossman School of MedicineSpeaker
Profile
Shohei Koide, Ph.D. is a synthetic protein scientist. His research integrates mechanistic biochemistry and directed evolution to create highly functional but still simple proteins. He is the inventor of the FN3 Monobody technology, and has made important contribution to synthetic antibody technologies. He has pioneered many applications of synthetic binding proteins to biology, chemistry and medicine. Previously he was Professor at University of Chicago and at University of Rochester School of Medicine and Dentistry. He is an elected fellow of the AAAS and the National Academy of Inventors. He is a co-founder of Aethon Therapeutics.
Agenda Sessions
Chairperson’s Remarks
, 13:55View SessionTargeting Intracellular Cancer Drivers with Monobodies
, 16:30View Session